Trials / Completed
CompletedNCT00521040
Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
Evaluation of the Efficacy and Safety of Levocetirizine During 8 Weeks Preceding and Following the Anticipated Onset of the Grass Pollen Season in Subjects Suffering From Seasonal Allergic Rhinitis Associated With Pollen-induced Asthma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 459 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine dihydrochloride |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2007-08-27
- Last updated
- 2013-12-12
Source: ClinicalTrials.gov record NCT00521040. Inclusion in this directory is not an endorsement.